In 2016, Dr. Michael A. Schmidt coauthored “Metabolomics Enables Precision Medicine: A White Paper, Community Perspective.”  This was part of the precision-personalized medicine initiative of the Metabolomics Society Precision Medicine & Pharmacometabolomics Task Group.  The paper was focused on the manner in which metabolomics can be used as an investigative tool in the development of precision medicine research (also often called personalized medicine) and as a clinical tool in the application of precision medicine.

On February 20 it was announced that “Metabolomics Enables Precision Medicine” won the 2017 award for Best Review Paper in Metabolomics.